 | Up a level |
- Library of Congress Subject Areas (3)
- R Medicine (3)
- RS Pharmacy and materia medica (3)
- RS400 Pharmaceutical chemistry (3)
- RS43.A64 Antineoplastic agents (3)
- RS400 Pharmaceutical chemistry (3)
- RS Pharmacy and materia medica (3)
- R Medicine (3)
Number of items at this level: 3.
1999
- Patterson, L. H., McKeown, S. R., Robson, T., Gallagher, R., Raleigh, S. M. and Orr, S. (1999) Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. Anti-Cancer Drug Design. 14(6), pp. 473-486. 0266-9536.
- Raleigh, S. M., Wanogho, E., Burke, M. D. and Patterson, L. H. (1999) Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug. Xenobiotica. 29(11), pp. 1115-1122. 0049-8254.
1998
- Raleigh, S. M., Wanogho, E., Burke, M. D., McKeown, S. R. and Patterson, L. H. (1998) Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone di-N-oxide prodrug. International Journal of Radiation Oncology, Biology, Physics. 42(4), pp. 763-767. 0360-3016.